CompuGroup Medical SE & Co. KGaA (CMPVF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CMPVF steht fuer CompuGroup Medical SE & Co. KGaA, ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 48/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 18. März 2026CompuGroup Medical SE & Co. KGaA (CMPVF) Gesundheitswesen & Pipeline-Uebersicht
CompuGroup Medical SE & Co. KGaA, a German-based healthcare IT provider, develops and distributes software solutions for various healthcare segments including ambulatory, pharmacy, and hospital settings. With a focus on digitalization and connectivity, the company serves a global customer base, facing competition in a rapidly evolving healthcare technology landscape.
Investmentthese
CompuGroup Medical presents a mixed investment case. The company's established presence in the healthcare IT sector and diverse product portfolio offer stability. The company's P/E ratio is high at 89.71, while its profit margin is relatively low at 1.5%. Growth catalysts include the increasing adoption of digital health solutions and expansion into new geographic markets. However, the company faces risks related to competition, regulatory changes, and integration of acquired businesses. Investors should carefully weigh these factors before considering an investment in CMPVF.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- CompuGroup Medical operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS), demonstrating a diversified revenue stream.
- The company's gross margin of 83.6% indicates strong pricing power and efficient cost management in its software and IT solutions.
- CompuGroup Medical serves a global customer base, including healthcare providers, pharmaceutical companies, health insurance companies, and consumers, reflecting a broad market reach.
- The company has a market capitalization of $1.74 billion, positioning it as a significant player in the healthcare IT sector.
- CompuGroup Medical offers a dividend yield of 0.22%, providing a modest income stream for investors.
Wettbewerber & Vergleichsunternehmen
Staerken
- Comprehensive product portfolio across multiple healthcare segments
- Strong presence in the European healthcare IT market
- Established customer base and long-term relationships
- Expertise in healthcare regulations and compliance
Schwaechen
- Relatively low profit margin compared to peers
- Dependence on the European market
- Limited presence in the US healthcare IT market
- High P/E ratio
Katalysatoren
- Ongoing: Increasing adoption of digital health solutions and electronic health records driving demand for CompuGroup Medical's products.
- Ongoing: Expansion into new geographic markets, particularly in Asia-Pacific, driving revenue growth.
- Upcoming: Potential acquisitions of complementary businesses to expand product portfolio and market share.
- Ongoing: Development and launch of new cloud-based solutions and services.
- Ongoing: Leveraging data analytics and AI to improve healthcare outcomes and efficiency.
Risiken
- Ongoing: Intense competition from established healthcare IT providers.
- Potential: Regulatory changes and data privacy concerns impacting the healthcare IT market.
- Potential: Cybersecurity threats and data breaches compromising sensitive patient data.
- Potential: Economic downturns and healthcare budget cuts reducing demand for healthcare IT solutions.
- Ongoing: Integration risks associated with acquired businesses.
Wachstumschancen
- Expansion in Telehealth Solutions: CompuGroup Medical can expand its telehealth solutions to capitalize on the growing demand for remote healthcare services. The telehealth market is projected to reach $55 billion by 2027, driven by factors such as increased access to care, cost savings, and convenience. CompuGroup Medical can leverage its existing IT infrastructure and customer base to offer integrated telehealth solutions to healthcare providers and patients, enhancing its market position.
- Strategic Acquisitions: CompuGroup Medical can pursue strategic acquisitions to expand its product portfolio and geographic reach. The healthcare IT market is fragmented, with numerous small and medium-sized players offering niche solutions. CompuGroup Medical can acquire companies with complementary technologies or market access to accelerate its growth and strengthen its competitive position. These acquisitions can provide access to new markets, technologies, and talent, driving long-term value creation.
- Cloud-Based Solutions: CompuGroup Medical can transition its software solutions to cloud-based platforms to improve scalability, flexibility, and cost-effectiveness. The cloud computing market in healthcare is projected to reach $77.9 billion by 2028, driven by factors such as data security, interoperability, and remote access. CompuGroup Medical can leverage cloud technologies to offer subscription-based services, reduce IT infrastructure costs, and enhance customer satisfaction.
- Data Analytics and AI: CompuGroup Medical can leverage data analytics and artificial intelligence (AI) to improve healthcare outcomes and efficiency. The healthcare analytics market is projected to reach $75 billion by 2028, driven by factors such as the need for improved decision-making, personalized medicine, and population health management. CompuGroup Medical can develop AI-powered tools to analyze patient data, predict disease outbreaks, and optimize treatment plans, providing valuable insights to healthcare providers and patients.
- International Expansion: CompuGroup Medical can expand its presence in emerging markets to capitalize on the growing demand for healthcare IT solutions. The healthcare IT market in Asia-Pacific is projected to grow at a CAGR of 12% from 2023 to 2028, driven by factors such as increasing healthcare expenditure, government initiatives, and technological advancements. CompuGroup Medical can leverage its expertise and product portfolio to offer customized solutions to healthcare providers in emerging markets, driving revenue growth and market share.
Chancen
- Expansion into emerging markets with growing healthcare expenditure
- Increased adoption of cloud-based healthcare solutions
- Leveraging data analytics and AI to improve healthcare outcomes
- Strategic acquisitions to expand product portfolio and geographic reach
Risiken
- Intense competition from established healthcare IT providers
- Regulatory changes and data privacy concerns
- Cybersecurity threats and data breaches
- Economic downturns and healthcare budget cuts
Wettbewerbsvorteile
- High Switching Costs: Customers face significant costs and disruption when switching to a different healthcare IT provider, creating customer stickiness.
- Integrated Solutions: CompuGroup Medical offers a comprehensive suite of integrated solutions across various healthcare segments, providing a competitive advantage.
- Established Customer Base: The company has a large and established customer base, providing a stable revenue stream and opportunities for cross-selling.
- Regulatory Expertise: CompuGroup Medical has deep expertise in healthcare regulations and compliance, which is a critical factor in the healthcare IT market.
Ueber CMPVF
Founded in 1987 and headquartered in Koblenz, Germany, CompuGroup Medical SE & Co. KGaA (CMPVF) has evolved into a leading provider of software and IT solutions for the healthcare sector worldwide. The company operates through four key segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment offers practice management software and electronic medical records for physicians and medical centers. The PCS segment provides software for pharmacies, focusing on administrative and billing processes. The HIS segment delivers clinical and administrative solutions for hospitals and rehabilitation centers. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases. CompuGroup Medical's solutions support healthcare providers in streamlining operations, improving patient care, and managing administrative tasks. The company's global reach extends to serving pharmaceutical companies, health insurance providers, and consumers. CompuGroup Medical changed its name from CompuGroup Medical SE to CompuGroup Medical SE & Co. KGaA in June 2020, reflecting its ongoing evolution and commitment to the healthcare IT market. The company's focus on innovation and digital transformation positions it to address the evolving needs of the healthcare industry.
Was das Unternehmen tut
- Develops and sells software for doctors' offices and medical centers.
- Provides software solutions for pharmacies to manage prescriptions and inventory.
- Offers clinical and administrative systems for hospitals and rehabilitation facilities.
- Creates IT solutions for healthcare providers, insurance companies, and patients.
- Provides IT security services for healthcare data protection.
- Offers data-based products and software interfaces for information sharing.
- Develops consumer portals and mobile apps for health management.
Geschaeftsmodell
- Software Licensing: Generates revenue through the sale and licensing of its software products to healthcare providers and institutions.
- Subscription Services: Offers subscription-based access to its cloud-based solutions and services.
- IT Services: Provides IT consulting, implementation, and support services to its customers.
- Data Analytics: Generates revenue from data analytics services, providing insights and reports to healthcare organizations.
Branchenkontext
CompuGroup Medical operates in the healthcare IT sector, which is experiencing rapid growth due to the increasing adoption of digital health solutions, electronic health records, and telehealth services. The market is competitive, with key players including BITGF (Allscripts Healthcare Solutions), BTTAY (Cerner Corporation), and DGWPF (Teladoc Health). CompuGroup Medical's focus on providing integrated solutions across various healthcare segments positions it to capitalize on the growing demand for digital healthcare technologies. The global healthcare IT market is projected to reach $390 billion by 2024, driven by factors such as government initiatives, technological advancements, and the need for improved healthcare efficiency.
Wichtige Kunden
- Registered Physicians and Medical Care Centers
- Pharmacies
- Acute Care Hospitals and Rehabilitation Centers
- Health Insurance Companies
- Pharmaceutical Companies
Finanzdaten
Chart & Info
CompuGroup Medical SE & Co. KGaA (CMPVF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer CMPVF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CMPVF.
Kursziele
Wall-Street-Kurszielanalyse fuer CMPVF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CMPVF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Daniel Gotthardt
CEO
Daniel Gotthardt serves as the CEO of CompuGroup Medical SE & Co. KGaA. His leadership is pivotal in guiding the company's strategic direction and operational execution. Information regarding his specific educational background and prior roles is not available in the provided data. However, as CEO, he is responsible for overseeing the company's global operations and driving its growth strategy in the healthcare IT market.
Erfolgsbilanz: As CEO of CompuGroup Medical, Daniel Gotthardt is responsible for leading the company's efforts to develop and deliver innovative healthcare IT solutions to customers worldwide. Specific achievements and milestones under his leadership are not detailed in the provided data. His focus is on driving the company's growth, enhancing its market position, and ensuring its long-term success in the rapidly evolving healthcare IT landscape.
CMPVF OTC-Marktinformationen
The OTC Other tier, where CompuGroup Medical SE & Co. KGaA trades, represents the lowest tier of the OTC market. Companies in this tier may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. These companies often have limited operating history, may be thinly traded, and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited liquidity and trading volume on the OTC market
- Lack of transparency and limited financial disclosure
- Potential for price manipulation and fraud
- Higher risk of financial distress or bankruptcy
- Limited regulatory oversight and investor protection
- Verify the company's registration and legal status
- Obtain and review the company's financial statements (if available)
- Assess the company's business model and competitive landscape
- Evaluate the company's management team and track record
- Research the company's history and any past legal or regulatory issues
- Understand the risks associated with investing in OTC stocks
- Consult with a financial advisor before making any investment decisions
- The company has been in operation since 1987.
- CompuGroup Medical serves a global customer base.
- The company operates in a regulated industry (healthcare IT).
- CompuGroup Medical has a market capitalization of $1.74 billion.
Haeufige Fragen zu CMPVF
What are the key factors to evaluate for CMPVF?
CompuGroup Medical SE & Co. KGaA (CMPVF) currently holds an AI score of 48/100, indicating low score. Key strength: Comprehensive product portfolio across multiple healthcare segments. Primary risk to monitor: Ongoing: Intense competition from established healthcare IT providers.. This is not financial advice.
How frequently does CMPVF data refresh on this page?
CMPVF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CMPVF's recent stock price performance?
Recent price movement in CompuGroup Medical SE & Co. KGaA (CMPVF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive product portfolio across multiple healthcare segments. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CMPVF overvalued or undervalued right now?
Determining whether CompuGroup Medical SE & Co. KGaA (CMPVF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CMPVF?
Before investing in CompuGroup Medical SE & Co. KGaA (CMPVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CMPVF to a portfolio?
Potential reasons to consider CompuGroup Medical SE & Co. KGaA (CMPVF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive product portfolio across multiple healthcare segments. Additionally: Strong presence in the European healthcare IT market. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CMPVF?
Yes, most major brokerages offer fractional shares of CompuGroup Medical SE & Co. KGaA (CMPVF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CMPVF's earnings and financial reports?
CompuGroup Medical SE & Co. KGaA (CMPVF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CMPVF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is based on available data and may be subject to change.
- AI analysis pending may provide further insights.